|
PHACTR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.944800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.900200E-03 |
| Normal-vs-Stage2 |
8.921000E-01 |
| Normal-vs-Stage3 |
3.966000E-01 |
| Normal-vs-Stage4 |
9.980300E-03 |
| Stage1-vs-Stage2 |
1.469190E-01 |
| Stage1-vs-Stage3 |
7.90430000000564E-05 |
| Stage1-vs-Stage4 |
1.05759999646793E-08 |
| Stage2-vs-Stage3 |
5.058200E-01 |
| Stage2-vs-Stage4 |
8.976100E-02 |
| Stage3-vs-Stage4 |
7.740300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.899600E-01 |
| Normal-vs-AfricanAmerican |
8.726800E-01 |
| Normal-vs-Asian |
1.533580E-01 |
| Caucasian-vs-AfricanAmerican |
4.543400E-01 |
| Caucasian-vs-Asian |
6.566000E-02 |
| AfricanAmerican-vs-Asian |
4.947800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.234400E-01 |
| Normal-vs-Female |
2.111000E-01 |
| Male-vs-Female |
3.396000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.262000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.184200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.128000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.687390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.710800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.794590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.609600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.436900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517830E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.874600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.164080E-02 |
| Normal-vs-Grade 2 |
5.844600E-03 |
| Normal-vs-Grade 3 |
5.095800E-01 |
| Normal-vs-Grade 4 |
1.112480E-02 |
| Grade 1-vs-Grade 2 |
1.920300E-02 |
| Grade 1-vs-Grade 3 |
7.800700E-03 |
| Grade 1-vs-Grade 4 |
2.123200E-03 |
| Grade 2-vs-Grade 3 |
5.76219999999239E-05 |
| Grade 2-vs-Grade 4 |
1.35379999988139E-07 |
| Grade 3-vs-Grade 4 |
2.446200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.357100E-04 |
| Normal-vs-ccB subtype |
9.844600E-01 |
| ccA subtype-vs-ccB subtype |
3.633500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.400800E-01 |
| Normal-vs-N1 |
8.654100E-02 |
| N0-vs-N1 |
9.964200E-02 |
|
|
